Safeguarding Heart, Brain, and Eye Health: TSH Biopharm’s Public Health Seminar Unveils Prescriptions for Wellness
2026.8.21
2026.8.13...
Biotech ESG Benchmark! TSH Biopharm Shines at AREA with Corporate Governance Award and Consecutive Win in Social Empowerment
2026.8.21
2026.06.29...
TSH Biopharm Breaches NT1.3BillionRevenueMilestonein2025withRecordEPSofNT3.63
2026.8.21
2026.03.27...
Profit Growth Outpaces Revenue: TSH Biopharm Posts 21% YoY Net Income Surge in First Three Quarters with EPS of NT$3.01
2026.8.21
2025.12.12...
.jpg)
To announce the expected date of the board of directors meeting to approve the consolidated financial statements is 2026/08/04 for the second quarter of 2026
2026.7.27
...
.jpg)
TSH Biopharm was invited to attend the institutional investor conference hosted by KGI Securities
2026.6.10
...
